While mTOR has been recognized as a key driver of metabolic reprogramming in NK cells, the mechanisms by which mTOR regulates the metabolic system and NK cell effector responses in the tumor microenvironment are still largely unknown. The gene discussed is MTOR; the disease is neoplasm.